Literature DB >> 23828144

Ultrasonographic quantification of hepatic-renal echogenicity difference in hepatic steatosis diagnosis.

Jing-Houng Wang1, Chao-Hung Hung, Fang-Ying Kuo, Hock-Liew Eng, Chien-Hung Chen, Chun-Mo Lee, Sheng-Nan Lu, Tsung-Hui Hu.   

Abstract

BACKGROUND AND AIM: Ultrasound (US) is recommended for hepatic steatosis screening. The purpose of this study was to determine the usefulness of US hepatic-renal echo-intensity (HR) difference in the quantitative assessment of hepatic steatosis.
METHODS: Consecutive patients undergoing liver biopsy were prospectively enrolled. Using US histogram technique, the mean gray level of hepatic parenchyma and right renal parenchyma at selected regions of interest were evaluated on the same day of biopsy. With steatosis assessed by histology as the reference, the diagnostic performances of HR difference in predicting the degree of steatosis was analyzed. The optimal cut-off level, diagnostic validity and post-test probability were assessed.
RESULTS: A total of 175 patients were enrolled (M/F, 103/72; mean age, 48.6 ± 11.7). There were 64 (36.5 %), 42 (24 %), 29 (16.6 %), 12 (6.9 %) and 28 (16 %) patients with steatosis of <5, 5-9, 10-19, 20-29 and ≥ 30 %, respectively. Multivariate analysis showed HR difference correlated with the severity of steatosis (R (2) = 0.425, p < 0.001) with positive correlation between HR difference and the severity of steatosis (r = 0.60, p < 0.001). The diagnostic performances were 0.927, 0.890, 0.816 and 0.760 for steatosis ≥ 30, ≥ 20, ≥ 10 and ≥ 5 %, respectively. The cut-off is 7 for diagnosing steatosis ≥ 30 %, with a negative predictive value of 97.6 %. The cut-off is 4 in predicting steatosis ≥ 5 %, with a positive predictive value of 79 %. The prevalence of steatosis influenced the post-test probability.
CONCLUSIONS: Quantitative assessment of HR difference with US histogram technique is useful in excluding moderate to severe hepatic steatosis.

Entities:  

Mesh:

Year:  2013        PMID: 23828144     DOI: 10.1007/s10620-013-2769-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Authors:  Magali Sasso; Michel Beaugrand; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Raoul Poupon; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2010-09-27       Impact factor: 2.998

3.  Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

Authors:  C-M Chu; D-Y Lin; Y-F Liaw
Journal:  Int J Obes (Lond)       Date:  2006-10-17       Impact factor: 5.095

4.  Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B.

Authors:  Fehmi Ateş; Mehmet Yalnız; Saadet Alan
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

5.  A tissue-specific adaptive texture filter for medical ultrasound images.

Authors:  Gjenna Stippel; Wilfried Philips; Paul Govaert
Journal:  Ultrasound Med Biol       Date:  2005-09       Impact factor: 2.998

6.  Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy.

Authors:  Chao-Hung Hung; Fang-Ying Kuo; Jing-Houng Wang; Sheng-Nan Lu; Tsung-Hui Hu; Chien-Hung Chen; Chuan-mo Lee; Hock-Liew Eng
Journal:  Antivir Ther       Date:  2006

Review 7.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

Authors:  Nina F Schwenzer; Fabian Springer; Christina Schraml; Norbert Stefan; Jürgen Machann; Fritz Schick
Journal:  J Hepatol       Date:  2009-06-11       Impact factor: 25.083

8.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

9.  Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.

Authors:  Marcello Mancini; Anna Prinster; Giovanni Annuzzi; Raffaele Liuzzi; Rosalba Giacco; Carmela Medagli; Matteo Cremone; Gennaro Clemente; Simone Maurea; Gabriele Riccardi; Angela Albarosa Rivellese; Marco Salvatore
Journal:  Metabolism       Date:  2009-08-28       Impact factor: 8.694

10.  The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study.

Authors:  Matthew J Hepburn; Jeffrey A Vos; Eric P Fillman; Eric J Lawitz
Journal:  BMC Gastroenterol       Date:  2005-04-13       Impact factor: 3.067

View more
  5 in total

1.  Test-retest reliability of echo intensity parameters in healthy Achilles tendons using a semi-automatic tracing procedure.

Authors:  Alessandro Schneebeli; Filippo Del Grande; Gabriele Vincenzo; Corrado Cescon; Marco Barbero
Journal:  Skeletal Radiol       Date:  2017-08-22       Impact factor: 2.199

2.  Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.

Authors:  Bo Zhang; Fang Ding; Tian Chen; Liang-Hua Xia; Juan Qian; Guo-Yi Lv
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

4.  Transfer learning with deep convolutional neural network for liver steatosis assessment in ultrasound images.

Authors:  Michał Byra; Grzegorz Styczynski; Cezary Szmigielski; Piotr Kalinowski; Łukasz Michałowski; Rafał Paluszkiewicz; Bogna Ziarkiewicz-Wróblewska; Krzysztof Zieniewicz; Piotr Sobieraj; Andrzej Nowicki
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-08-09       Impact factor: 2.924

Review 5.  Role of Ultrasound Methods for the Assessment of NAFLD.

Authors:  Golo Petzold
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.